Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
What is the role of beta-adrenergic signaling in heart failure?Lohse MJ; Engelhardt S; Eschenhagen TCirc Res 2003[Nov]; 93 (10): 896-906This review addresses open questions about the role of beta-adrenergic receptors in cardiac function and failure. Cardiomyocytes express all three beta-adrenergic receptor subtypes-beta1, beta2, and, at least in some species, beta3. The beta1 subtype is the most prominent one and is mainly responsible for positive chronotropic and inotropic effects of catecholamines. The beta2 subtype also increases cardiac function, but its ability to activate nonclassical signaling pathways suggests a function distinct from the beta1 subtype. In heart failure, the sympathetic system is activated, cardiac beta-receptor number and function are decreased, and downstream mechanisms are altered. However, in spite of a wealth of data, we still do not know whether and to what extent these alterations are adaptive/protective or detrimental, or both. Clinically, beta-adrenergic antagonists represent the most important advance in heart failure therapy, but it is still debated whether they act by blocking or by resensitizing the beta-adrenergic receptor system. Newer experimental therapeutic strategies aim at the receptor desensitization machinery and at downstream signaling steps.|*Signal Transduction[MESH]|Adrenergic beta-Antagonists/therapeutic use[MESH]|Animals[MESH]|Cyclic AMP-Dependent Protein Kinases/metabolism[MESH]|Disease Models, Animal[MESH]|GTP-Binding Proteins/metabolism[MESH]|Heart Failure/drug therapy/*physiopathology[MESH]|Humans[MESH]|Mice[MESH]|Mice, Transgenic[MESH]|Myocardium/*metabolism[MESH]|Receptors, Adrenergic, beta/genetics/*metabolism[MESH]|beta-Adrenergic Receptor Kinases[MESH] |
